Work

Error in Text

Year: 2020
Type: article
Abstract: JAMA Surgery for the opportunity to reply to the letters to the editor. 1 Shi et al advised that combining patients without postoperative pancreatic fistula (POPF) and with biochemical leakage may have biased the analysis regarding long-term survival in patients receiving neoadjuvant therapy (NAT). While biochemical leakage may reflect a more preserved gland function, which has been associated with better survival in upfront resected pancreatic cancer, 2 a preliminary analysis had shown no significant differences between biochemical leakage and no pancreatic fistula in patients with NAT.
Source: JAMA Surgery
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4243349474
FWCI:
Cites: 1
Cited by:
Related to: 10